Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: Antigens for multi-targeted antibody-guided therapy

导出原文传递

翻译打印收藏纠错

作者： Chauhan SC ^[1] ; Vinayek N ^[2] ; Maher DM ; Bell MC ; Dunham KA ; Koch MD ; Lio Y ; Jaggi M

作者单位： Univ S Dakota, Dept Math, Vermillion, SD 57069 USA ^[1] Univ S Dakota, Sanford Sch Med, Canc Biol Res Inst, Dept Lab Med, Sioux Falls, SD USA ^[2]

关键词 ovarian cancer ovarian cancer therapy TAG-72 MUC1 CA125 MURINE MONOCLONAL-ANTIBODY DISSEMINATED PERITONEAL DISEASE TARGETED DRUG-DELIVERY INTRAPERITONEAL RADIOIMMUNOTHERAPY RADIOLABELED ANTIBODIES PHASE I/II IMMUNOLIPOSOMES EXPRESSION MODEL PACLITAXEL

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

The Journal of Histochemistry and Cytochemistry

2007年55卷8期

867-875页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: Antigens for multi-targeted antibody-guided therapy

The Journal of Histochemistry and Cytochemistry

相似文献

The Journal of Histochemistry and Cytochemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: Antigens for multi-targeted antibody-guided therapy

The Journal of Histochemistry and Cytochemistry

相似文献

The Journal of Histochemistry and Cytochemistry

相关期刊

检索历史清除